Ethiopia Working to Become Continental Pharmaceutical Manufacturing Hub

At the African Healthcare Manufacturing Trade Exhibition in Addis Ababa, the Ethiopian Health Ministry outlined plans to position Ethiopia as a continental hub for pharmaceutical manufacturing. State Minister Dr. Muluken emphasized that Ethiopia aims to grow its pharmaceutical market to over $4 billion by 2030, leveraging the African Continental Free Trade Area. The event focused on enhancing investment, technology transfer, and regulatory cooperation to reduce import dependence. Dr. Tadesse Teferi, President of the Ethiopian Pharmaceuticals and Medical Supplies Manufacturing Industries Sectoral Association, highlighted Ethiopia's infrastructure and its WHO Maturity Level 3 regulatory authority as key advantages. He stated that Ethiopia aspires to become a hub for vaccines, insulin, and oncology medications within the next decade. Stakeholders, including the Federation of African Pharmaceutical Manufacturers Associations, underscored the importance of supply security and pooled procurement mechanisms to connect African demand with reliable local production.